The LIVESTRONG at the YMCA exercise program significantly improved physical activity, fitness, and quality of life in survivors of cancer.
In patients with tumor lysis syndrome, rasburicase was significantly more effective in treating hyperuricemia and was associated with significantly shorter ICU stay.
Treatment with naldemedine improved opioid-induced consiptation in a timely manner and was well tolerated in patients with cancer.
The well-being of patients' informal caregivers is associated with perceived quality of care among patients with cancer.
Gains against cardiovascular disease, especially in Western Europe, is likely a cause for the shift.
Cigarette smoking is more common among survivors of AYA cancer than those without cancer, and smoking is associated with greater comorbidities and poorer general health.
Structured Exercise Programs Effectively Lead to Increased Physical Activity Among Trial ParticipantsApril 15, 2016
A structured exercise program more effectively increased physical activity among patients participating in a clinical trial.
Cancer survivors use mind-body therapies (MBTs) to manage their cancer-related symptoms, but this use may differ for each cancer survivorship stage.
Cancer programs are performing moderately well with regard to communicating the importance of psychosocial care to patients.
Unmarried patients with a first primary, invasive cancer appear to have worse survival compared with married patients.
Fifteen percent of older adults are at risk for a major drug-drug interaction due to increased use of prescription medications.
Patients with cancer who died at home had similar or longer survival compared with patients who died in a hospital.
Adding netupitant to a chemotherapy-induced nausea and vomiting (CINV) regimen can improve outcomes without increased toxicity.
Active screening and symptom management in patients with cancer reduces depression, pain, and fatigue.
A popular mobile health (mHealth) app for a smartphone that measures blood pressure (BP) was found highly inaccurate.
Both patient and nurse characteristics may be associated with discussions about complementary and alternative medicine (CAM).
Ramucirumab administered at a dose of 10 mg/kg every 21 days for 3 cycles did not produce significant prolongation of corrected QT (QTc).
Latino patients with advanced cancer who discussed their end-of-life (EOL) care with their clinicians were more likely to complete a do-not-resuscitate (DNR) order.
Cancer-related financial burden was linked to lower health-related quality of life (HRQoL).
Patients with cancer seem to prefer to receive information regarding incidental germline variants found during the process of tumor profiling.
A higher proportion of cancer survivors in the United States report use of vitamins/minerals and complementary and alternative medicine (CAM).
The analgesia-first sedation approach is crucial to adequate pain management in critically ill oncology patients on mechanical ventilation.
A recent study examined the risk of cardiovascular disease for the survivors of adolescent and young adult cancer.
Adding fosaprepitant to palonosetron and dexamethasone reduced the risk for nausea and emesis in patients undergoing radiotherapy.
Ovarian cancer isn't a single disease, but rather a number of different malignancies, and better understanding is needed to improve prevention and treatment according to a U.S. panel.
Regular tea drinkers had fewer heart attacks, and had less calcium build-up in their arteries.
Significant improvement was achieved in obtaining written informed consent and providing patient education.
Oral morphine, oxycodone, transdermal fentanyl, and buprenorphine provided similar pain control, response rates, in patients with cancer pain.
Type 1 diabetes was associated with differences in the risk for developing several common cancers.
A staffing template based on daily patient volume and hours of operation with defined nurse roles and responsibilities.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|